Results 81 to 90 of about 7,354,999 (259)

DermAll nanomedicine for allergen-specific immunotherapy [PDF]

, 2013
A novel allergen-specific immunotherapy for IgE-mediated allergies is presented in this paper, using an experimental allergic rhinitis model and a synthetic plasmid pDNA/PEIm nanomedicine expressing ovalbumin as model allergen.
Csiszovszki Zsolt, Tőke Enikő R., Molnár Levente, Lőrincz Orsolya, Kemény Lajos, Francziszti, László, Bitai Tamás, Csörgő Sándorné Bata Zsuzsanna, Lőrincz, Orsolya, Molnár, Levente, Bitai, Tamás, Jánossy Tamás, Lisziewicz Julianna, Csiszovszki, Zsolt, Tőke, Enikő Rita, Garaczi, Edina, Jánossy, Tamás, Bata-Csörgő, Zsuzsanna, Kemény, Lajos, Lisziewicz, Julianna, Szabó, Kornélia, Szabó Kornélia Ágnes, Garaczi Edina, Francziszti László   +23 more
core   +1 more source

Postcode‐Level Variation and Environmental Determinants of Respiratory Allergies in a Large German Cohort

Allergy, EarlyView.
Young children (0–9 years) and residents of urban areas appeared particularly vulnerable to respiratory allergy development and exacerbation. Incidence showed nonlinear associations with PM10, PM2.5, temperature, and alder/birch pollen, while DPMR showed similar patterns, except for NO2 and the interaction O3*NO2.
Trang Dao‐Siebel, Christoph Knote, Christoph Müller, Thilo Erbertseder, Elke Hertig, Roxana Halbleib, Evelyn Lamy   +6 more
wiley   +1 more source

Comparative analysis of sublingual and subcutaneous allergen-specific immunotherapy in children with bronchial asthma sensitized to pollen allergens: effect on cytokine profile and immune response

Zdorovʹe Rebenka
Background. Allergen-specific immunotherapy is currently the only disease-modifying treatment for allergic disea­ses. Among its delivery methods, sublingual (SLIT) and subcutaneous (SCIT) immunotherapy are commonly used.
M.P. Prokhorova, A.V. Kupkina
doaj   +1 more source

Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 response

EBioMedicine, 2019
Background: BM32, a grass pollen allergy vaccine containing four recombinant fusion proteins consisting of hepatitis B-derived PreS and hypoallergenic peptides from the major timothy grass pollen allergens adsorbed on aluminium hydroxide has been shown ...
Julia Eckl-Dorna, Milena Weber, Victoria Stanek, Birgit Linhart, Robin Ristl, Eva E. Waltl, Sergio Villazala-Merino, Andrea Hummel, Margarete Focke-Tejkl, Renate Froeschel, Angela Neubauer, Rainer Henning, Thomas Perkmann, Rudolf Valenta, Verena Niederberger   +14 more
doaj   +1 more source

Intestinal STING‐(Over)activation—A Contributing Factor to Food Allergies?

Allergy, EarlyView.
Sophie Goebel, Hannah Ruth Schiller
wiley   +1 more source

Determinants of Poor Health‐Related Quality of Life in Patients With Food Allergy

Allergy, EarlyView.
Machine‐learning analysis of 502 well‐characterised food‐allergic patients was used to identify key determinants of poor FA‐HRQL, defined as FAQLQ ≥ 5. The most relevant predictors were adult age, female sex, multiple food allergies, severe reactions, need for urgent care, onset before 18 years, and longer disease duration.
Rosialzira Natasha Vera‐Berrios, Alejandro Gonzalo‐Fernández, Natalia Freundt‐Serpa, Guadalupe Marco‐Martín, Beatriz Fernández‐Parra, María Isabel Alvarado‐Izquierdo, Rocío Casas‐Saucedo, Cristina Stein‐Coronado, Ethel Ibáñez‐Echevarría, Tania Ramos‐García, María Dolores Alonso‐Díaz de Durana, Azahara López‐Raigada, Carlos Blanco‐Guerra, María Pía de Calzada‐Bustingorri, Teresa Carrillo‐Díaz, Hilda Rianec Hernández‐Suárez, Miguel Ángel Díaz‐Palacios, Sonsoles Infante‐Herrero, Ana María Nieto‐Nieto, Sonia Vázquez‐Cortés, Eloína González‐Mancebo, María M. Escribese, Pilar Rico‐Nieto, Domingo Barber, Montserrat Fernández‐Rivas   +24 more
wiley   +1 more source

Practical Recommendations for Mixing Allergy Immunotherapy Extracts

Allergy & Rhinology, 2015
Critical aspects of formulating allergy immunotherapy vaccines include the selection, total number, and proportions of each allergen component in therapeutic mixtures.
Barbara J. Daigle M.S.N., F.N.P.-C., Donna J. Rekkerth M.S., F.N.P.   +1 more
doaj   +1 more source

ALLERGEN-SPECIFIC IMMUNOTHERAPY: VACCINES FOR ALLERGIC DISEASES

Медицинская иммунология, 2015
Allergen-specific immunotherapy (ASIT) is the most effective method of allergy treatment which consists of exposure to small doses of antigen responsible for development of allergic condition in the particular patient.
A. S. Fedorov, L. S. Litvinova, V. I. But-Gusaim, S. N. Litvinenko   +3 more
doaj   +1 more source

Surgical Management of Non‐Allergic Rhinitis—An EAACI Task Force Position Paper

Allergy, EarlyView.
ABSTRACT Non‐allergic rhinitis is a frequent yet underdiagnosed cause of chronic nasal symptoms, including nasal congestion, rhinorrhoea, and upper airway hyperreactivity. Its pathophysiology involves neurogenic dysregulation, leading to excessive mucus production and vasodilation.
Marie Lundberg, Julie van Waterschoot, Mathilde Moyaert, Adam Chaker, Philippe Gevaert, Jan Hagemann, Valérie Hox, Maarten Kleijwegt, Ludger Klimek, Devyani Lal, Juan Maza‐Solano, Oliver Pfaar, Fabio Simon Ryser, Michele Shiappoli, Diana Silva, Sanna Toppila‐Salmi, Johanna Wikstén, Sietze Reitsma, Laura Van Gerven   +18 more
wiley   +1 more source

Frequency of new sensitization in patients experiencing symptom recurrence during allergen immunotherapy

Egyptian Journal of Chest Disease and Tuberculosis
Introduction Allergen immunotherapy should be personalized according to the allergen sensitization pattern and the clinical impact of allergens. Sensitization, or the existence of antibodies for specific allergens, is a necessary step for developing an ...
Eman A. Saied, Mohammed Shehta, Ahmad Y. Badawy, Heba W. Abdelwahab   +3 more
doaj   +1 more source